Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Gastroenteritis

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

Intestinal Obstruction II: Pathophysiology

Intestinal Obstruction II: Pathophysiology

Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Capillary refill for the assessment of circulatory dysfunction in sepsis: A scoping review.

The American journal of emergency medicine·2025

Same author

Correlation of Narrative Evaluations to Clerkship Grades Using Statistical Sentiment Analysis.

Medical science educator·2022

Same author

Association of Emergency Department Pediatric Readiness With Mortality to 1 Year Among Injured Children Treated at Trauma Centers.

JAMA surgery·2022

Same author

Point-Of-Care Capillary Refill Technology Improves Accuracy of Peripheral Perfusion Assessment.

Frontiers in medicine·2021

Same author

The MCAT Was a Barrier to Diversity Long Before COVID-19.

Academic medicine : journal of the Association of American Medical Colleges·2021

Same author

A dangerous pandemic pair: Covid19 and adolescent mental health emergencies.

The American journal of emergency medicine·2020

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

Neutropenic enterocolitis.

Robert L Cloutier¹

¹Department of Emergency Medicine, Doernbecher Children's Hospital, Oregon Health & Science University, 3181 Sam Jackson Park Road, Portland, OR 97239, USA. cloutier@ohsu.edu

Hematology/Oncology Clinics of North America

|May 22, 2010

Summary

This summary is machine-generated.

Neutropenic enterocolitis, a serious complication of neutropenia, arises from chemotherapy damaging the gut. Early diagnosis and prompt treatment are crucial for patient survival.

More Related Videos

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Related Experiment Videos

Last Updated: Jun 12, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Area of Science:

Gastroenterology
Oncology
Internal Medicine

Background:

Neutropenic enterocolitis (NE), also known as typhlitis or ileocecal syndrome, is a severe complication in patients with neutropenia, often linked to malignancy.
It results from chemotherapy-induced damage to the intestinal lining during periods of low neutrophil counts.
NE can rapidly escalate to life-threatening conditions such as intestinal perforation, organ failure, and sepsis.

Purpose of the Study:

To highlight the critical nature of neutropenic enterocolitis.
To emphasize the importance of prompt diagnosis and intervention in managing this condition.
To inform healthcare professionals about the signs, symptoms, and potential outcomes of NE.

Main Methods:

This abstract is based on a review of existing medical literature and clinical knowledge regarding neutropenic enterocolitis.
It synthesizes information on the pathophysiology, clinical presentation, and management strategies.
No new clinical data was generated for this summary.

Main Results:

Neutropenic enterocolitis presents with symptoms including fever, abdominal pain, nausea, vomiting, and diarrhea.
The condition is associated with significant morbidity and mortality if not managed aggressively.
Early recognition is key to initiating appropriate medical and/or surgical interventions.

Conclusions:

Neutropenic enterocolitis is a rare but critical complication in neutropenic patients, particularly those with cancer.
Timely and aggressive medical and/or surgical management are essential for improving patient outcomes.
Vigilance for characteristic symptoms is paramount for rapid identification and treatment.